Clario
↗Philadelphia, USA
Clario is a leading clinical research technology company that provides digital endpoint solutions for the pharmaceutical and biotechnology industries. Formed in 2021 through the merger of ERT and Bioclinica, the company specializes in collecting and analyzing high-quality clinical evidence through electronic Clinical Outcome Assessments (eCOA), cardiac safety monitoring, medical imaging, and respiratory efficacy services.
In October 2025, Thermo Fisher Scientific announced a definitive agreement to acquire Clario for approximately $8.88 billion. The company is recognized for its global scale, having supported over 30,000 clinical trials and contributing to more than 700 FDA and EMA new drug approvals. Clario integrates advanced AI and cloud-native technologies to streamline data collection and enhance the accuracy of clinical trial endpoints.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Clinical Trial Technology & CRO Services
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$1.25B
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Acquired
Total Raised:$8.88B (Acquisition Value)
Investors:Nordic Capital, Astorg, Novo Holdings
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:eCOA, Medical Imaging, Cardiac Safety (ECG/ABPM), Respiratory (Spirometry), Precision Motion (Wearables)
Active Trials:26000
Trial Phases:Phase 1: 5000 | Phase 2: 8000 | Phase 3: 10000 | Phase 4: 3000
FDA Approvals:700
EMA Approvals:700
CORPORATE STRUCTURE
Parent Company:Thermo Fisher Scientific (Post-merger)
Acquired By:Thermo Fisher Scientific (Pending) (2025-10-01)
Subsidiaries:Bioclinica, ERT, NeuroRx, ArtiQ, iCardiac Technologies
Key Partnerships:PathAI (AI-powered digital pathology for GI trials), Cognizant (Global strategic technology services), AWS (Generative AI for clinical data analysis), University of Oxford (Parkinson's research using Opal sensors)
COMPETITION
Position:Leader
Competitors:Medidata (Dassault Systèmes), Signant Health, IQVIA, Veeva Systems, ICON plc, Parexel
LEADERSHIP
Key Executives:
Chris Fikry, M.D. - CEO
Jason Knoblauch - CFO
Jay Ferro - EVP, Chief Information, Technology & Product Officer
Scientific Founders:Joel Morganroth, M.D. (Founder of ERT)
Board Members:Rod MacKenzie (Chair), Raj Shah (Nordic Capital), Daniel Berglund (Nordic Capital)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Clario. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.